Literature DB >> 1244422

Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.

B Chesebro, K Wehrly.   

Abstract

The humoral immune response to Friend virus leukemia was studied in congenic F1 mice differing in their incidence of recovery from leukemia. Antiviral neutralizing antibodies rose in titer in vivo concurrently with disappearance of viremia and fall in spleen virus levels. Cytotoxic antileukemia cell antibodies also appeared at this time. Passive transfer of these antibodies could inactivate low numbers of leukemia cells in vivo; however, mice of both high and low recovery genotypes produced antibodies in equal titer and recovered from viral infection in spite of striking differences in recovery from leukemic splenomegaly. Mice lacking C57BL genes did not produce antibodies or recover from viremia except in rare instances. Recovery from splenomegaly was found to be influenced by three or more C57BL genes independent of the H-2 complex.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1244422      PMCID: PMC2190092          DOI: 10.1084/jem.143.1.73

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

Authors:  B R Brodeur; T C Merigan
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  The humoral antibody response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.

Authors:  E W Lamon; E Klein; B Andersson; E M Fenyö; H M Skurzak
Journal:  Int J Cancer       Date:  1973-11-15       Impact factor: 7.396

Review 3.  Formation and dissociation of virus-antibody complexes with special reference to the neutralization process.

Authors:  S E Svehag
Journal:  Prog Med Virol       Date:  1968

4.  Induction and regression of primary moloney sarcoma virus-induced tumors in mice.

Authors:  A Fefer; J L McCoy; J P Glynn
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

5.  Transformation of spleen cells three hours after infection in vivo with Friend leukemia virus.

Authors:  G B Rossi; G Cudkowicz; C Friend
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

6.  In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.

Authors:  D H Lavrin; R B Herberman; M Nunn; N Soares
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

7.  Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.

Authors:  M Harada; G Pearson; L Redmon; E Winters; S Kasuga
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

8.  Effects of interferon on leukaemia virus activation in graft versus host disease.

Authors:  M S Hirsch; D A Ellis; M R Proffitt; P H Black
Journal:  Nat New Biol       Date:  1973-07-25

Review 9.  Antitumor effects of interferon.

Authors:  I Gresser
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

10.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  33 in total

1.  Direct determination of the point mutation rate of a murine retrovirus.

Authors:  R J Monk; F G Malik; D Stokesberry; L H Evans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Interference established in mice by infection with Friend murine leukemia virus.

Authors:  T Mitchell; R Risser
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.

Authors:  B Chesebro; K Wehrly; D Doig; J Nishio
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Replication-defective Friend murine leukemia virus particles containing uncleaved gag polyproteins and decreased levels of envelope glycoprotein.

Authors:  J K Collins; B Chesebro
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

5.  Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.

Authors:  B Chesebro; K Wehrly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Differing T-cell requirements for recombinant retrovirus vaccines.

Authors:  K J Hasenkrug; D M Brooks; J Nishio; B Chesebro
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 7.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

8.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia.

Authors:  B Chesebro; M Bloom; K Wehrly; J Nishio
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

Review 10.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.